SinoMab BioScience Limited

HKEX:3681.HK

1.19 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017
Operating Activities:
Net Income -243.111-284.158-288.194-122.6-276.282-83.61-51.901
Depreciation & Amortization 36.06427.03120.3210.6738.4895.3424.918
Deferred Income Tax 018.257-109.5394.3210010.682
Stock Based Compensation 18.9955.01762.89734.903007.336
Change In Working Capital 48.343-23.27446.642-39.22442.9595.781-14.157
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 0000000
Other Working Capital 48.343-23.27446.642-39.22442.9595.223-12.081
Other Non Cash Items 5.862-43.411120.811-29.4112.34525.6582.922
Operating Cash Flow -133.847-300.538-147.063-141.338-222.489-46.829-40.2
Investing Activities:
Investments In Property Plant And Equipment -103.338-112.751-198.232-75.955-42.286-2.746-0.823
Acquisitions Net 033.36-16.173-17.332022.3579.041
Purchases Of Investments -41-75-85-69.565000
Sales Maturities Of Investments 41.11175.566177.04686.897000
Other Investing Activites 6.306-2.533-15.343-103.26301.8552.097
Investing Cash Flow -96.921-81.358-137.702-179.218-42.28621.46610.315
Financing Activities:
Debt Repayment 80.458000000
Common Stock Issued 10.03846.085-59.67301,437.461500.035
Common Stock Repurchased 00-59.6730000
Dividends Paid 0000000
Other Financing Activities -8.22966.765339.079-12.522-6.6586.44589
Financing Cash Flow 82.267102.28557.515-18.8081,420.802-3.55589.035
Other Information:
Effect Of Forex Changes On Cash 9.27859.515-20.137-51.1343.3294.334-1.462
Net Change In Cash -139.223-220.096-247.387-390.4981,159.356-24.58457.688
Cash At End Of Period 203.664342.887562.983810.371,200.86841.51266.096